Whittemore, 1994, Prostate cancer, vol 19, 309
2003
Song, 2005, Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men, J Korean Med Sci, 20, 262, 10.3346/jkms.2005.20.2.262
Roehl, 2004, Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results, J Urol, 172, 910, 10.1097/01.ju.0000134888.22332.bb
D’Amico, 2000, Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer, J Clin Oncol, 18, 1164, 10.1200/JCO.2000.18.6.1164
Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591
Hull, 2002, Cancer control with radical prostatectomy alone in 1,000 consecutive patients, J Urol, 167, 528, 10.1016/S0022-5347(01)69079-7
Latini, 2004, Differences in clinical characteristics and disease-free survival for Latino, African-American, and non-Latino white men with prostate cancer: data from CaPSURE, J Urol, 171, 124, 10.1016/S0022-5347(18)37729-2
Lam, 2004, Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer?, J Urol, 172, 1856, 10.1097/01.ju.0000141783.67470.55
Egawa, 2001, A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically respectable prostate cancer in Japanese men, Jpn J Clin Oncol, 31, 74, 10.1093/jjco/hye018
Hsu, 2004, E-cadherin expression in prostate adenocarcinoma in Chinese and its pathological correlates, Urol Int, 73, 36, 10.1159/000078802
Egawa, 2001, Treatment outcome by risk group after radical prostatectomy in Japanese men, Int J Urol, 8, 295, 10.1046/j.1442-2042.2001.00301.x
Freedland, 2005, The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy, J Urol, 174, 1276, 10.1097/01.ju.0000173907.84852.ec
Man, 2003, Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer, J Urol, 170, 901, 10.1097/01.ju.0000081423.37043.b4
Derweesh, 2004, Continuing trends in pathological stage migration in radial prostatectomy specimens, Urol Oncol, 22, 300, 10.1016/j.urolonc.2003.11.011
van Houten, 2000, Differences in reproductive endocrinology between Asian men and Caucasian men—a literature review, Asian J Androl, 2, 13
Wu, 2001, Lifestyle determinants of 5α-reductase metabolites in older African-American, white, and Asian-American men, Cancer Epidemiol Biomarkers Prev, 10, 533
Hoffman, 2000, Is low serum free testosterone a marker for high grade prostate cancer?, J Urol, 163, 824, 10.1016/S0022-5347(05)67812-3
Zhang, 2002, Association between prostate cancer and serum testosterone levels, Prostate, 53, 179, 10.1002/pros.10140
Massengill, 2003, Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy, J Urol, 169, 1670, 10.1097/01.ju.0000062674.43964.d0
Raivio, 2003, Reduced circulating androgen bioactivity in patients with prostate cancer, Prostate, 55, 194, 10.1002/pros.10234